Oxytocin secretion is important for the normal progress of parturition in the rat. We tested the hypotheses that contractions of the uterus before pup delivery activate oxytocin neurons, and that they do so via a noradrenergic projection. In anesthetized 22-day (term) pregnant rats, iv oxytocin pulses enhanced both uterine contractile activity and the firing rate of oxytocin and vasopressin neurons in the supraoptic nucleus, and these were significantly correlated. The same oxytocin treatment also increased the expression of Fos in both the supraoptic nucleus and the nucleus of the tractus solitarius, but not in 21-day pregnant or virgin rats. In five of eight rats on the day of expected parturition, noradrenaline release in the supraoptic nucleus (sampled by microdialysis) exhibited sudden peaks during oxytocin administration, seen in only one of nine rats given vehicle pulses. Noradrenaline release was significantly greater in rats that went into labor or gave birth to a pup than in rats not in labor. In rats infused with the ␣ 1 -noradrenergic receptor antagonist, benoxathian, into the supraoptic nucleus before and during iv oxytocin administration, Fos expression in supraoptic neurons was significantly less than that in vehicle controls. Thus, at term pregnancy, uterine contractions activate both oxytocin and vasopressin neurons in the SON, and this activation involves a noradrenergic pathway. (Endocrinology 142: [633][634][635][636][637][638][639][640][641][642][643][644] 2001) P ARTURITION CAN occur in the absence of oxytocin in the mouse, as is apparent from oxytocin gene knockout studies (1, 2). Nevertheless, oxytocin antagonists administered before or during parturition in the rat delay the onset and progress of delivery of young, respectively (3), suggesting an important role for oxytocin in the control of normal parturition, at least in this species.
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During parturition in the rat, the firing rate of magnocellular oxytocin neurons in the rat supraoptic nucleus (SON) is increased, and superimposed upon this elevated electrical activity are intermittent high frequency bursts of action potentials, which occur at about the time of delivery of each pup (4) and lead to pulsatile oxytocin secretion from the posterior pituitary (5, 6) . The response of the rat uterus to systemic oxytocin administration increases on the day of delivery, in the last few hours before labor starts (7) , and the pulsatile pattern of oxytocin appears to be particularly efficacious, as the onset of labor and optimal progress of parturition (8, 9) can be promoted by pulsatile administration of oxytocin at doses that are less effective when given continuously (9) . Uterine contractions and the passage of fetuses through the birth canal further enhance oxytocin secretion; thus, oxytocin release from the pituitary during parturition is driven by a positive feedback loop (the Ferguson reflex) (10) .
This positive feedback is relayed via a neuronal pathway through the brainstem (11) including the A2 neurons of the nucleus of the tractus solitarius (NTS). Neurons in both the SON and the NTS express Fos during parturition, reflecting their activation at this time, and pulsatile administration of oxytocin to term pregnant rats results in the induction of Fos expression at both sites even before birth is induced (8, 9) . Triple labeling has shown that some of these NTS neurons are both retrogradely labeled from the SON and contain tyrosine hydroxylase, the rate-limiting enzyme in noradrenaline synthesis (12) .
The above pattern of Fos expression in the SON and NTS during birth superficially resembles that after iv cholecystokinin (CCK). CCK increases the firing rate of oxytocin neurons, accompanied by increased Fos expression in the SON and increased oxytocin secretion (13, 14) ; CCK also induces Fos expression (8, 14) in noradrenergic neurons in the NTS and increases noradrenaline release within the SON (15) , and local destruction of the noradrenergic innervation of the SON by selective neurotoxins prevents CCK-induced Fos expression in the SON, but not expression in the NTS or in the intact SON contralateral to the lesion (14) . Thus, noradrenaline appears to mediate the activation of oxytocin neurons in the SON after systemic CCK. As noradrenaline release within the SON increases immediately before and during parturition (16) , we hypothesized that this noradrenergic pathway may also mediate positive feedback from the contracting uterus to the SON.
In these experiments we tested the hypotheses that contractions of the uterus before the delivery of pups activate oxytocin neurons, and that they do so via a noradrenergic projection to the SON. Here, we studied intrauterine pressure changes, the electrical activity of identified SON neurons, and Fos expression in the SON in term pregnant, anesthetized rats during pulsatile oxytocin administration. We also measured noradrenaline release in the SON and studied the effects of blocking the actions of endogenous noradrenaline by infusion of an ␣ 1 -noradrenergic antagonist (benoxathian) into the SON during pulsatile oxytocin administration.
Materials and Methods Animals
Virgin female rats were mated overnight with sexually experienced males, and pregnancy was confirmed by finding a vaginal plug of semen (day 0 of pregnancy). Rats were housed singly under standard laboratory conditions (12-h light, 12-h dark cycle, 22 C, 60% humidity, food and water ad libitum) after mating. Within each experiment all rats were age matched. During experimental procedures all rats were maintained under anesthesia throughout.
Effect of oxytocin pulse administration on uterine contractile activity and SON neuron firing rate in term pregnant rats
On the day of expected parturition (day 22 of pregnancy), 16 Sprague Dawley (Edinburgh) or Wistar (Babraham) rats were anesthetized with urethane (ethyl carbamate, 1.25 g/kg) or pentobarbitone (18 mg in 0.3 ml; Sagatal, Rhone Merieux Ltd., Harlow, UK) given ip on the morning of experiment. The two anesthetics were used in both Edinburgh and Babraham, and this allowed comparison of the traditionally used urethane with pentobarbitone, which is known not to induce SON neuron activation (17) . Rats were laparotomized by a lateral longitudinal incision, and one horn of the pregnant uterus was removed from the abdominal cavity and kept moist with warm 0.9% saline. A small pursestring suture was made between the first and second pups from the ovarian end using a curved needle and fine silk thread. A small incision was made in the middle of the purse-string suture, and a deflated latex balloon (condom tip) connected to saline-filled polyethylene tubing was inserted between two pups. The uterine incision was closed and secured by drawing the purse-string suture together. The uterine horn was returned to the abdominal cavity, and the abdominal wall and skin incisions were sutured closed. In some rats, a balloon was inserted in this way into both uterine horns to compare their contractile activities. In other rats a second balloon was inserted in the cervix (per vaginum). The balloon(s) was filled with 1-1.5 ml saline and was connected to a voltmeter via a pressure transducer; pressure was sampled at 1 Hz and recorded using Spike 2 computer software on a personal computer.
For uterine inflation/deflation experiments, in eight rats the pup at the cervical end in the horn of the uterus was removed and replaced with a balloon filled with approximately 4 ml saline, the volume of which could be decreased or increased by withdrawal or injection of saline to effect deflation or inflation, respectively.
The jugular vein and the trachea were then cannulated. The SON and the neural stalk of the pituitary were exposed using a ventral surgical approach as described previously (18) . Briefly, a bipolar stimulating electrode was placed on the neural stalk, and the electrical activity of single SON neurons was recorded extracellularly using a glass micropipette filled with 0.9% saline, introduced into the SON under visual control. Neurons identified as projecting to the neurohypophysis by antidromic activation were classified as oxytocin or vasopressin cells on the basis of firing pattern and response to CCK (20 g/kg, iv; Sigma, Dorset, UK). Oxytocin cells fired continuously and were excited by iv administration of CCK. Vasopressin cells fired phasically or continuously and were either inhibited or showed no response to iv CCK (19) .
After a control period of 30 -60 min, iv bolus injections of oxytocin were administered (10 mU for 2 h and 20 mU for 2 h; Syntocinon, Sandoz Pharmaceuticals Corp., Basel, Switzerland; each pulse was in 20 or 30 l given every 10 min, diluted in 0.9% NaCl, and was administered in less than 2 s; maximum volume injected over 4 h was 760 l/pregnant rat, which has a total blood volume of ϳ20 ml). Four control rats received no iv oxytocin injections while the SON neuron firing rate and/or uterine pressure were continuously recorded for up to 3 h. To analyze the effects of oxytocin administration on uterine and cervical pressure and cell activity, each experiment was divided into a control period, before any drug administration, and four 1-h periods of oxytocin administration. Uterine and cervical pressure were measured, and the baseline pressure, frequency, and amplitude of contractions were calculated in the last 10 min of each experimental period; the mean pressure was calculated as the arithmetic average of the recorded values, the frequency of contractions by counting the number of peaks in each 10-min period (defined as a rise and fall in pressure of at least 3 mmHg), and the amplitude of contractions by taking the pressure at each peak and subtracting the lowest pressure before the next peak.
The firing rate of cells (mean Ϯ sem spikes/sec, in 60-sec bins) was used as the measure of cell activity, except when the activity pattern was phasic (putative vasopressin neurons), at which point the activity quotient (the proportion of time that a cell is active) and the intraburst firing rate were also calculated. The effect of the oxytocin pulses was measured by comparing firing rate in the control period with the last 10 min of each hour of oxytocin administration.
The correlation coefficient between intrauterine pressure in two uterine horns in the same rat, between intrauterine pressure and intracervical pressure in the same rat, or between intrauterine pressure and SON neuron activity in the same rat were calculated over each separate 1-h period.
Uterine pressure was not recorded in the following experiments to avoid induction of SON neuron activity and Fos expression during the additional surgical procedures.
Effect of oxytocin pulse administration on Fos expression in the SON and NTS
Virgin (287 Ϯ 20 g BW) and late pregnant (21 and 22 days; 418 Ϯ 10 and 442 Ϯ 18, respectively; each with 8 -16 fetuses in utero) Sprague Dawley rats were anesthetized with Sagatal as described above [Sagatal does not induce Fos in the SON (17) ], and a jugular vein was cannulated. At least 1 h after surgery, iv injections (pulses) were given every 10 min for 4 h; the rats received pulses of either isotonic saline (30 l) or oxytocin [Syntocinon; 30-l pulses of 10 mU for 2 h, followed by 20 mU for 2 h, (8) ]. Ten minutes after the last pulse, the rats were killed by decapitation, and their brains and brainstems were rapidly removed and frozen in crushed dry ice. Virgin rats injected ip with hypertonic saline (1.5 m NaCl, 4 ml/kg) were killed after 90 min, and their brains were collected as described above as positive technical controls; hyperosmotic stimulation activates Fos expression in both oxytocin and vasopressin neurons in the SON (20) . The tissues were stored at Ϫ70 C until sectioning and immunocytochemistry.
To assess whether Fos was expressed in oxytocin and/or vasopressin neurons, additional 22-day pregnant rats were treated similarly (vehicle pulses, n ϭ 4; oxytocin pulses, n ϭ 4) to generate tissue for double immunocytochemistry. Virgin rats were not investigated due to their known lack of basal Fos protein expression [in frozen brains (21) and in perfused-fixed brains (22) ]. After pulse treatment the rats were perfusedfixed transcardially with heparinized isotonic saline and 4% paraformaldehyde in 0.1 m PBS; the brain and brainstem were removed and postfixed in 15% sucrose in 4% paraformaldehyde followed by 30% sucrose in PBS for 2 days and then frozen on dry ice before storage at Ϫ70 C and processing.
Effect of oxytocin pulse administration on noradrenaline release in the SON
Seventeen 22-day pregnant Sprague Dawley rats were anesthetized with Sagatal on the morning of experiment (as described above), and a jugular vein was cannulated. A microdialysis probe (concentric semipermeable membrane, 1 mm long and 0.5 mm wide; CMA12, Carnegie Medicin, Biotech Instruments Ltd. (Kimpton, UK); prepared according to the manufacturer's instructions), flushed with degassed filtered artificial cerebrospinal fluid (aCSF) at 1.3 l/min, was stereotaxically positioned in the SON (1.1 mm caudal and 1.8 mm lateral to bregma, and 8.9 mm below the surface of the dura with the skull level). After flushing for more than 1 h, microdialysis samples were collected at intervals of 10 -15 min. Basal samples were collected for 60 min, then rats were given iv pulses of either vehicle (n ϭ 9) or oxytocin [n ϭ 8; every 10 min at 10 mU for 60 min (first period), then 20 mU for 60 min (second period)]. Samples were collected into tubes containing 2% perchloric acid (1 l/7 l, vol/vol, dialysate) at 4 C to prevent oxidation of noradrenaline. Dialysate samples were rapidly frozen on dry ice within 10 min of collection. After the experiment, the brains were collected from the rats, fixed in 10% formol saline, histologically stained, and examined for probe location; only data from rats with confirmed probe location within the SON were analyzed. The in vitro recovery rate of the microdialysis probes, measured by HPLC followed by electrochemical detection or by the percent recovery of [ 3 H]noradrenaline in dialysates, was 9.8 Ϯ 0.4%. Noradrenaline was quantified at The Babraham Institute using reverse phase HPLC with electrochemical detection (M460 ECD, Waters Corp., Milford, MA; in conjunction with a BAS 6-mm Unijet detector cell) according to the method of Mefford (23) . Aliquots of 8 l were injected onto a 2 ϫ 150-mm Sphereclone ODS2 column (Phase Separations, Deeside, UK) via a CMA200 autoinjector (Carnegie Medicin). Data capture and integration were performed using the Gynkotek Software system (Severn Analytical, Macclesfield, UK) run on a personal computer. Samples from vehicle-and oxytocin-treated rats were analyzed randomly; standards and blank controls were analyzed before each batch of experimental samples. The limit of detection for the noradrenaline was 1.3 pg/8 l. All rats had at least eight fetuses in utero; mean maternal body weight was 414 Ϯ 13 g.
Effect of an intra-SON infusion of a noradrenergic antagonist on Fos expression in the SON induced by oxytocin pulse administration in pregnant rats
Under halothane anesthesia (2-3% in oxygen-N 2 O at 1200 ml/min for 25 min) pregnant Sprague Dawley rats were fitted via a dorsal stereotaxic approach with a 8.6-mm long, 22-gauge guide cannula (Plastics One, Inc., Semat, St. Albans, UK) unilaterally in the SON (1.1 mm caudal and 1.8 mm lateral to bregma with the skull level between and bregma) 2 days before the experiment; the cannula was held in position with dental cement fixed to the skull with two screws. On day 22 of pregnancy (384 Ϯ 17 g BW), the rats were anesthetized with Sagatal (18 mg, ip), and a jugular vein cannula filled with heparinized saline was implanted. At least 1 h later an intra-SON infusion [0.8 l/h for 2 h from a gas-tight 10-l Hamilton syringe (Reno, NV; Supplier, Sigma, driven by a Braun perfusor pump] of either aCSF or the noradrenergic ␣ 1 -antagonist, benoxathian (Sigma; 1 or 10 g/ml, dissolved in aCSF), was begun using a 28-gauge injection cannula (Plastics One, Inc.), which projected 0.5 mm beyond the tip of the guide cannula into the SON. After 30 min of infusion, iv pulses of isotonic saline or oxytocin (Syntocinon, 20 mU/30 l, at 30 l every 10 min) were started and continued for 90 min. Thus, there were four groups: rats receiving an aCSF infusion in the SON given iv pulses of vehicle or oxytocin, and rats receiving 1 g/l benoxathian or 10 g/l benoxathian infusion in the SON and given iv oxytocin pulses. Ten minutes after the last pulse, the rats were given a lethal dose of Sagatal iv and perfused-fixed transcardially with heparinized isotonic saline and then paraformaldehyde in PBS; the brain and brainstem were removed and postfixed as described above. The location of the cannula tip near the SON (Ͻ0.5 mm laterally and dorsally) was confirmed in the processed sections.
Effect of intra-SON infusion of a noradrenergic antagonist on the expression of Fos in the SON induced by osmotic stimulation
Under halothane anesthesia, virgin Sprague Dawley rats were fitted with a guide cannula unilaterally in a SON, as described above, 2 days before experiment. On the day of experiment, the rats (253 Ϯ 9 g BW) were anesthetized with Sagatal, and a jugular vein cannula was implanted. One hour later an intra-SON infusion (flow rate, 0.8 l/h for 2 h) of either aCSF or benoxathian (1 g/l) was begun. After 30 min of infusion the rats received an ip injection of hypertonic saline (1.5 m NaCl, 4 ml/kg). Ninety minutes later, the rats were given an overdose of Sagatal and perfused-fixed transcardially, and the brain was removed and prepared as described above.
Fos immunocytochemistry
From the nonfixed frozen brains 15-m coronal cryostat sections were cut through the SON and NTS and mounted on gelatinized slides. Immunocytochemistry for Fos was performed as previously described (24) . Briefly, sections containing SON (ϳ1000 -1300 m caudal from bregma) (25) or NTS (ϳ500 m rostral to obex, also containing area postrema) were then fixed, and endogenous peroxidase was deactivated. The sections were preincubated in normal sheep serum and incubated for 36 h at 4 C with a polyclonal antiserum against Fos (Oncogene Science, Inc.; Supplier, Cambridge Bioscience, Cambridge, UK; 1:1000), then in the second antibody (antirabbit IgG complex, peroxidase labeled, Vector Laboratories, Inc. Peterborough, UK; 1:500) for 24 h at 4 C. Nuclear staining was enhanced using the nickel-intensified (glucose-amino-oxidase) 3Ј,3Ј-diaminobenzidine (DAB) method (21) . The sections were dehydrated, cleared in xylene, and coverslipped. Fos-positive nuclei in the SON (ϳ16 SON profiles/rat) and NTS (ϳ4 NTS bilateral profiles/rat) were counted, with the identity of the sections coded, using a microscope with a ϫ10 objective and a brightfield condenser. For each rat the number of Fos-positive neurons per unit area SON or NTS (i.e. per mm 2 ) was calculated by dividing the number of Fos-positive neurons by the area of the SON, which was measured using Image (NIH image analysis computer program). Sections from all pregnant rats were processed together, but additional virgin rats given vehicle or oxytocin pulses were processed separately and counted by the same person who processed the sections from the pregnant rats. Slides from positive control rats (given hypertonic saline) were included in each immunocytochemistry run as technical controls.
Coronal sections (50 m) cut from perfused-fixed brains on a freezing microtome were processed by Fos immunocytochemistry using a freefloating method as previously described (8) . Briefly, endogenous peroxidase was deactivated, and sections were preincubated in normal sheep serum. Sections were incubated in a polyclonal antiserum against Fos (Cambridge Bioscience; 1:1000 diluted in phosphate buffer with 0.2% Triton X-100 and 1% normal sheep serum) for 36 h at 4 C, then in second antibody using an ABC kit (Vectastain Elite, Vector Laboratories, Inc.) and visualized using the nickel-enhanced DAB reaction. The sections were then mounted on gelatinized slides, dehydrated, cleared, and coverslipped. Fos-positive neurons were counted in both infused (ipsilateral) and contralateral sides of the SON and in the NTS on coded slides as described above. Fos-positive nuclei in the SON (20 -24 SON profiles/rat) and NTS (4 NTS bilateral profiles/rat, at the rostro-caudal level of the area postrema) were counted, and for each rat the number of Fos-positive neurons per unit area SON or NTS was calculated as described above. Sections from all rats from each experiment were counted by the same person. Slides from positive control rats were included in each immunocytochemistry run as technical controls.
Double immunolabeling
Sections containing SON were double labeled for Fos and oxytocin or Fos and vasopressin; sections containing NTS were double labeled for Fos and tyrosine hydroxylase. Coronal sections (40 m) were cut on a freezing microtome and processed first by Fos immunocytochemistry as described above, resulting in a black color visible in the nucleus of positive neurons. The sections were then preincubated again with 1% normal sheep serum and incubated with either a polyclonal antiserum against oxytocin (1:2000; a gift from Dr. T. Higuchi, Fukui, Japan), a monoclonal antiserum against vasopressin (1:2000; Chemicon International, Inc., Temecula, CA), or a monoclonal antiserum against tyrosine hydroxylase (1:400; Chemicon International, Inc.). Visualization was achieved using H 2 O 2 and DAB and resulted in brown cytoplasmic color visible in positive neurons. The sections were then mounted on gelatinized slides, dehydrated, cleared, and coverslipped. The number of Fos-positive neurons was counted in 10 SON or NTS profiles per rat; as dense cell packing made accurate counting of the number of oxytocin or vasopressin cells in the SON difficult, the data are expressed as the percentage of Fos-positive cell nuclei associated with cytoplasmic oxy-tocin or vasopressin labeling. Sections from all pregnant rats were processed together for the double immunolabeling.
Statistical analysis
Data are presented as the group mean Ϯ sem; P Ͻ 0.05 was considered statistically significant. For experiments on uterine activity, a 2 test was used to evaluate the difference in effect of oxytocin pulses between the experimental group and the control group. For the cell firing rate, all multiple comparisons were made with one-way ANOVA for repeated measures, and single comparisons were by Student's t test. A Genstat software program was used to analyze correlations between uterine/ cervical pressure and electrical activity of SON neurons. The z-test was used to compare proportions in the microdialysis experiment. For other experiments, statistical analysis was performed using SigmaStat for Windows (Jandel Scientific, San Rafael, CA) statistical software. ANOVA (one or two way) for repeated measures was used to compare paired data and consecutive samples.
Results

Effect of oxytocin pulse administration on uterine contractile activity in term pregnant rats
In four control rats that did not receive oxytocin pulse administration, uterine mean pressure and/or amplitude showed no significant changes and tended to decrease progressively (mean pressure change, Ϫ5.3 Ϯ 4 mmHg; amplitude change, Ϫ2.8 Ϯ 2.5 mmHg). By contrast, in each of 10 rats given oxytocin pulses, uterine pressure was stable in the control period, but in response to oxytocin either the amplitude of contractions increased, reflecting increased force of contractions, or the mean intrauterine pressure increased, sometimes with a reduction in the peak-trough amplitude of contractions, reflecting a sustained increase in contractile tonus. In 7 of the 10 rats mean intrauterine pressure increased by between 0.7 and 23 mmHg throughout the course of oxytocin administration. In 6 rats (including 3 rats with no increase in mean pressure and 1 rat with a Ͻ1 mmHg increase in mean pressure) the amplitude of contractions increased to between 3.3 and 8.5 mmHg from a preinjection control amplitude of 2.9 Ϯ 0.2 mmHg (0.1 Ͼ P Ͼ 0.05 compared with controls, by 2 test). There was no consistent change in the frequency of contractions, which occurred at intervals of 40 -90 sec in each rat (for examples, see Fig. 1 ).
In three rats, uterine pressure was recorded from both uterine horns (e.g. Fig. 1B) . The contractile activity of the two horns within each rat was not tightly synchronized in the control period; there was no consistent phase relationship between contractions in one horn and those in the other, but the activity in the two horns was positively correlated by the end of the oxytocin administration in each experiment (r 2 ϭ 0.74, 0.85, and 0.9 respectively; each P Ͻ 0.05), and in one case it switched from a negative correlation (r 2 ϭ Ϫ0.78) in the control period to a positive correlation (r 2 ϭ 0.74) in the fourth hour of oxytocin administration.
Effect of oxytocin pulse administration on cervical contractile activity in term pregnant rats
In five rats intracervical pressure was recorded concomitantly with intrauterine pressure (e.g. Fig. 1D ), and in another two rats intracervical pressure alone was recorded. The baseline pressure in the cervix during oxytocin administration declined in all but one rat; it decreased most rapidly in the first hour of oxytocin administration. However, in six of the seven rats, the amplitude of cervical pressure changes increased with oxytocin administration (to 1.6 -31 mmHg) and remained greater at the end of oxytocin administration than in the control period (P Ͻ 0.05, by one-way ANOVA for repeated measures). Intracervical pressure was not significantly correlated with intrauterine pressure during either the control period or the final period of oxytocin administration, and there were no periods of consistent synchrony between cervical and uterine activities with oxytocin administration. There was no consistent change in the frequency of contractions.
The type of anesthetic used did not influence the uterine or cervical responses to oxytocin pulse administration.
Effect of oxytocin pulse administration on SON neuron firing rate in term pregnant rats
Oxytocin cells. Ten oxytocin cells were identified in the SON of term pregnant rats with simultaneous intrauterine pressure recording. Five of these were recorded throughout the initial 1-h control period and the subsequent 4 h of treatment; the other cells were each recorded for at least 2 h during part of the experimental protocol. All cells showed an increase in continuous activity during oxytocin administration (by oneway ANOVA for repeated measures, P Ͻ 0.01) compared with the control period, with no evidence of pulsatile activation (burst firing, see Fig. 1, A and B) . In eight oxytocin neurons that were recorded through a control period and for the whole of the first hour of oxytocin administration, the firing rate was significantly higher at the end of the first hour than in the control period (mean change, ϩ1.0 Ϯ 0.3 spikes/s; P Ͻ 0.05, by paired t test). Seven cells were recorded throughout the second hour, and five of these showed a further increase in activity, whereas the firing rate of the other two cells remained above the initial control rate (mean change from first to second hour, ϩ0.2 Ϯ 0.2 spikes/sec).
Vasopressin cells. Nine vasopressin cells were recorded during oxytocin administration. Six cells were recorded through a control period and for the whole of the first hour of treatment; their firing rate was significantly higher at the end of the first hour than in the control period (see Fig. 1 , C and D; mean change, ϩ0.6 Ϯ 0.2 spikes/s; P Ͻ 0.05, by paired t test). Three of six cells showed a further significant increase in activity from the first to the second hour. Seven cells were recorded for 3 h during pulse administration. Six of the seven cells showed a significant increase from the second to the third hour and displayed significantly higher firing rates than first recorded (by one-way ANOVA for repeated measures, P ϭ NS; by paired t test, P Ͻ 0.05, first period compared with control, and third period compared with first). The activity quotient increased in five of the vasopressin cells, and the intraburst firing rate increased in all of the vasopressin cells (both P Ͻ 0.05; although in one cell this was not sustained until the end of oxytocin administration).
The activity of one oxytocin and one vasopressin cell was recorded over periods of 2-3 h without intervention. In these experiments no significant changes were observed in cell firing rate (control period to end, 2.5 Ϯ 0.1 to 2.2 Ϯ 0.1 and 4.5 Ϯ 0.2 to 4.2 Ϯ 0.2 spikes/sec in oxytocin and vasopressin cells, respectively).
Correlation between intrauterine pressure and neuronal activity
The correlation between SON neuron electrical activity and intrauterine pressure was calculated for both oxytocin and vasopressin cells. Thirteen cells (seven oxytocin and six vasopressin) were examined, in which recordings of both neuron firing rate and intrauterine pressure were made. During the control period the correlation coefficients were not significantly different from zero (oxytocin cells: P ϭ 0.76; range of r 2 ϭ Ϫ0.98 to ϩ0.62; vasopressin cells: P ϭ 0.25; range of r 2 ϭ Ϫ0.4 to ϩ0.33). The correlation coefficient significantly increased between the control period and the last treatment period for both oxytocin (P ϭ 0.046, by paired t test vs. control period) and vasopressin cells (P ϭ 0.045, by paired t test vs. control period). Thus, the correlation coefficients for the vasopressin cells were significantly different from zero at the end of stimulation (P ϭ 0.044; range of r 2 ϭ Ϫ0.02 to ϩ0.69), and statistical significance was almost reached for oxytocin cells (P ϭ 0.059; range of r 2 ϭ ϩ0.43 to ϩ0.83).
Whereas oxytocin cells fire continuously, vasopressin cells generally fire phasically, with bursts of 20-to 60-sec duration separated by silent periods of around 20-sec duration (see Fig. 2C ) (62) . Despite the overall correlation of vasopressin cell firing rate with intrauterine pressure, phasic bursts of activity were not consistently synchronized with uterine contractions in any cell. However, for one vasopressin cell that showed a clear phasic activity and was recorded throughout 4 h of oxytocin pulse treatment, a strong association between burst periodicity and individual uterine contractions was apparent. For this cell, the correlation of firing rate to mean intrauterine pressure over the entire 4-h oxytocin pulse treatment was highly significant ( Fig. 2A; r 2 ϭ 0.46; P Ͻ 0.01). Additionally, each 200-sec interval throughout this period of recording was analyzed statistically and revealed a positive correlation between uterine pressure and cell activity for FIG. 1. Effect of oxytocin pulses on uterine contractile activity and SON neuronal firing rate in anesthetized pregnant rats. Day 22 pregnant rats were anesthetized, a saline-filled balloon connected to an exteriorized cannula was inserted into the uterine lumen between two pups, a jugular vein was cannulated, and the SON was exposed by ventral surgery for electrophysiological recording. Neurons were identified as projecting to the neurohypophysis and pharmacologically by their responses to iv CCK (excitatory for oxytocin and inhibitory for vasopressin). All rats were given pulsatile iv injections of oxytocin (10 or 20 mU, 30 l, at arrows) every 10 min [time of each pulse injection represented by arrow (2)]. Typical recordings of oxytocin neurons from rats with simultaneous intrauterine pressure recording (A) and simultaneous intrauterine pressure recording in both uterine horns of the same rat (B); the excitatory response to CCK is also shown (s). Typical recordings of vasopressin neurons from rats with simultaneous intrauterine pressure recording (C) and with simultaneous intrauterine and intracervical pressure recording from the same rat (D). Horizontal bars, 10 min. almost every interval (r 2 ϭ 0.35-0.6; overall P Ͻ 0.01), and this was apparent as a clear overall relationship between spike probability and the phase of uterine contraction (Fig.  2 , B and C, firing rate and intrauterine pressure recording for the same cell). No significant correlations were found for the intrauterine pressure and cell firing rate in the control, untreated rats.
No significant correlations were found between cervical pressure and cell activity for any of the four oxytocin cells and three vasopressin cells studied, either in the control period (with oxytocin cells, 0.59, Ϫ0.4, 0.7, and 0.03; with vasopressin cells, Ϫ0.58, Ϫ0.6, and Ϫ0.03) or after oxytocin pulse administration (with oxytocin cells, 0.25, Ϫ0.32, Ϫ0.06, and 0.4; with vasopressin cells, 0.28, 0.34, and 0.66).
In eight rats the activities of four oxytocin and five vasopressin cells were recorded while a balloon placed in the lower uterus (i.e. replacing a pup) was inflated or deflated by injection or removal of 1.5-4 ml warm saline from an attached syringe. Oxytocin cells showed a small, but consistent, decrease in electrical activity during uterine distension induced by balloon inflation and a corresponding increase in activity after deflation ( Fig. 3 ; P Ͻ 0.05, by t test, comparison of pre-and poststimulus value; for four cells mean decrease after inflation, 0.6 Ϯ 0.08 spike/sec). Vasopressin cells showed a less consistent response to inflation and deflation, with no overall significance detected.
Effect of oxytocin pulse administration on Fos expression in the SON and NTS
Fos expression in the SON was low in virgin vehicletreated rats (2.0 Ϯ 1.3 Fos-positive neurons/mm 2 ) and did not significantly increase after oxytocin pulse administration. On day 21 of pregnancy, Fos expression was not significantly different from that in virgin animals in either vehicle-or oxytocin-treated rats. On day 22 of pregnancy there were more Fos-positive nuclei in vehicle-treated rats than on day 21 (P Ͻ 0.05; Fig. 4A ). Oxytocin pulses induced a further significant increase in the number of neurons expressing Fos compared with the vehicle-treated rats on the same day (by two-way ANOVA, P Ͻ 0.0001; by Newman-Keuls post-hoc test, P Ͻ 0.05) and compared with oxytocin-treated day 21 pregnant rats (P Ͻ 0.05; Fig. 4A ). The number of neurons expressing Fos in the SON on day 22 of pregnancy was approximately one third of that in the hypertonic salinepositive controls (585 Ϯ 141 Fos-positive nuclei/mm 2 SON; n ϭ 4).
In a few 22-day pregnant rats sections of SON were double labeled for Fos and oxytocin or Fos and vasopressin. Fos was found in both oxytocin and vasopressin magnocellular neurons after both vehicle treatment (43.9 Ϯ 6.6% and 52.9 Ϯ 5.7% of Fos labeled cells, respectively) and oxytocin treatment (45.8 Ϯ 3.1% and 51.8 Ϯ 3.7% cells, respectively) and was not significantly different between groups.
Fos expression in the NTS was low in vehicle-treated day 21 pregnant rats and did not significantly increase after oxytocin pulses (Fig. 4B) . Rats on day 22 of pregnancy given oxytocin pulses showed significantly more Fos-positive nu-
Correlation between vasopressin neuron activity and intrauterine pressure. A, Correlation analysis of electrical activity of a supraoptic vasopressin neuron and intrauterine pressure was performed for each 200-sec interval of the entire 4-h oxytocin pulse treatment. There was a significant correlation for most of the 200-sec intervals and thus an overall highly significant correlation between the increase in electrical activity and the increase in uterine pressure (r 2 ϭ 0.46; P Ͻ 0.01, by Genstat analysis). B, Electrical activity (top graph; calculated for 80 sec in 1-sec bins after each oxytocin pulse) of a vasopressin neuron (same as in A) with simultaneous uterine activity (bottom trace) for all pulses during the last 2 h of the oxytocin pulse treatment; there was an apparent synchronization of electrical activity and intrauterine pressure after each pulse of oxytocin. The upper graph was constructed as a postevent time histogram where the triggering event was a local maximum of uterine pressure, marking the peak of uterine contraction; the lower graph shows the waveform correlation of uterine activity to these peaks. Thus, these graphs represent the average uterine contraction over the 2-h recording period and the associated probability of cell firing. This association between peaks of contraction and probability of cell firing reflected the tendency of bursts of activity in the phasic cell to be initiated during peaks of uterine pressure. Horizontal bar, 40 sec. C, A sample portion of the entire record illustrating this tendency. Horizontal bar, 10 min.
clei in the NTS than rats given vehicle pulses (by ANOVA, P Ͻ 0.0001; Fig. 4B ) or rats given oxytocin pulses on day 21. Fos expression in tyrosine hydroxylase-positive neurons comprised 29.0 Ϯ 12.3% of all Fos-expressing neurons in vehicle-treated rats and 37.4 Ϯ 11.0% of all Fos-expressing neurons in rats treated with oxytocin pulses (P ϭ NS).
In this experiment all of the oxytocin-pulse treated rats on day 22 of pregnancy went into labor or gave birth during the experiment compared with two of the vehicle pulse-treated rats on day 22 of pregnancy even though they remained under anesthesia; none of the rats given either vehicle or oxytocin pulses on day 21 of pregnancy showed any signs of labor or birth.
Effect of oxytocin pulse administration on noradrenaline release in the SON
Of the nine vehicle-treated rats, one gave birth to a pup during the experiment. Two of the vehicle-treated rats showed strong signs of labor before the experiment (presence of blood/mucus at vaginal opening and abdominal contractions); thus, three rats (33%) in the vehicle group were in labor or gave birth. In oxytocin-treated rats, four of eight (50%) gave birth to one or more pups during the second injection period. In the rats that showed clear signs of labor or later gave birth to a pup (four oxytocin-treated and three in vehicle-treated rats), the mean basal noradrenaline content in dialysates from the SON was 49.1 Ϯ 11.9 pg/ml (mean of the four samples before pulses started), significantly greater than that in rats with no signs of labor (19.6 Ϯ 7.1 pg/ml; n ϭ 10; P Ͻ 0.05, by t test).
The noradrenaline content of the dialysates did not change significantly in rats given vehicle pulses and that were not in labor or did not give birth to a pup (Fig. 5A) . In both the oxytocin-treated group and the labor/pup group, some rats exhibited peaks of noradrenaline content (Fig. 5, B-D) . Peaks were defined as noradrenaline content reaching a value of greater than 5 sd from the mean of the basal samples for that rat. The proportion of rats showing 1 or more noradrenaline peaks was significantly greater for oxytocin-treated and labor/pup groups (8 of 11 rats) than for the vehicle-pulsed group (0 of 6 rats; by z-test to compare proportions, P Ͻ 0.05).
Of oxytocin-treated rats, 5 of 8 exhibited peaks of noradrenaline, all of which were observed during the second postbasal sampling period when the high concentration pulses of oxytocin were administered. Of vehicle-treated rats, 2 of 9 exhibited peaks of noradrenaline during the basal control period; these were the 2 rats in labor, and the peaks were not related to the vehicle pulses. Of vehicle-treated rats, 1 of 9 exhibited a peak during the second postbasal sampling period, and this was in the rat that gave birth to a pup.
Effect of intra-SON infusion of a noradrenergic antagonist on Fos expression in the SON induced by oxytocin pulse administration in pregnant rats
In day 22 pregnant vehicle-treated controls, the numbers of Fos-positive nuclei were 248.3 Ϯ 115.6 and 180.4 Ϯ 66.5/ A, Fos expression in the SON in virgin (n ϭ 4 and 9 for vehicle and oxytocin groups, respectively), 21-day pregnant (n ϭ 5 and 5, respectively), and 22-day pregnant (n ϭ 6 and 7, respectively) rats. By two-way ANOVA: P Ͻ 0.0001. by Newman-Keuls post-hoc tests: *, P Ͻ 0.05 vs. day 21; #, P Ͻ 0.05 between oxytocin-treated and vehicle control on same day. B, Fos expression in the NTS in 21-day pregnant (n ϭ 5 and 4) and 22-day pregnant (n ϭ 6 and 7) rats given vehicle or oxytocin pulses, respectively. By one-way ANOVA: P Ͻ 0.05; #, P Ͻ 0.05 compared with all other groups. mm 2 in the SON ipsilateral and contralateral to the infusion side, respectively. Intravenous oxytocin pulses for 90 min induced a significant increase (by 2.6-and 2.4-fold, respectively) in Fos expression in the SON in rats that received an aCSF infusion in the SON (by two-way ANOVA, P Ͻ 0.0001 across groups; Fig. 6, A and B ; by Student's Newman Keuls post-hoc test, P Ͻ 0.05 compared with vehicle-treated rats). Infusion of benoxathian into one SON before and during the oxytocin pulses at concentrations of 1 and 10 g/l strongly attenuated the oxytocin-induced Fos expression in the infused ipsilateral side compared with the effect of aCSF (P Ͻ 0.05, by post hoc test ; Fig. 6A) ; thus, numbers of Fos-containing neurons in the oxytocin-treated groups treated with benoxathian in the SON were not significantly different from those in the vehicle-treated controls (Fig. 6A) . Fos expression was also significantly attenuated in the contralateral SON (at a benoxathian concentration of 10 g/l; P Ͻ 0.05, by post-hoc test; but not the 1 g/l dose; Fig. 6B ). The number of Fos-positive neurons was counted separately in the dorsal SON region (defined as dorsal of the line between the lateral ventral edge of the SON and the top of the dorsal, lateral edge of the optic chiasm, previously described as the predominant location of oxytocin neurons), ipsilateral to the infusion side. The ratio of labeled neurons in the dorsal SON/whole SON was not significantly different after benoxathian compared with vehicle infusion in the oxytocin-treated rats (benoxathian, 0.49 Ϯ 0.03; vehicle, 0.49 Ϯ 0.02), indicating that Fos expression was attenuated similarly by benoxathian in both the oxytocin-rich SON area and the whole SON, which also contains vasopressin neurons.
Oxytocin pulses for 90 min in day 22 pregnant rats also significantly increased Fos expression in the NTS vs. vehicle (P Ͻ 0.05, by t test; Fig. 6C ). Benoxathian infusion in the SON did not alter the number of oxytocin-induced Fos-positive nuclei in the NTS (Fig. 6C) , and there was no significant difference between the ipsi-and contralateral sides (individual data not shown).
In these rats, 6 of 19 oxytocin-pulse treated rats went into labor or gave birth during the experiment compared with none of the vehicle pulse-treated rats; benoxathian infusion in the SON had no significant effect on whether labor started at either dose (4 of 6 rats that were in labor were given benoxathian).
Effect of intra-SON infusion of a noradrenergic antagonist on Fos expression in the SON induced by osmotic stimulation
Fos expression in SON neurons was high in osmotically stimulated virgin rats, as expected, with 2273 Ϯ 400 positive nuclei/mm 2 in controls (mean of both SON in vehicle-treated rats). Infusion of benoxathian into the SON did not significantly attenuate the Fos expression induced by osmotic stimulation in either the ipsilateral or contralateral sides (Fig. 7) compared with that in vehicle-treated rats.
Discussion
This study has shown that in anesthetized pregnant rats, pulses of oxytocin given every 10 min for 4 h that result in an increase in uterine contractile activity also increase the electrical activity of both oxytocin and vasopressin neurons in the SON. The average increase in electrical activity, most of which occurred during the first hour of treatment, was similar for both oxytocin and vasopressin cells and amounted to nearly one spike per sec, which is about a 30% increase above normal spontaneous firing rates and is similar in magnitude to the firing rate response in oxytocin neurons evoked by iv CCK, although it is sustained rather than transient (26) .
It appears that the contractile activity of the uterus is itself the source of activation of neurons in the SON. As uterine activity, at least in the two horns, was not tightly synchronized in basal control recordings and was poorly correlated with cervical activity, a tight correspondence between uterine contractions in any one horn and neural activity could not be anticipated. Nonetheless, the activity of the two horns of the uterus was positively correlated after oxytocin treatment in the experiments in which both were measured simultaneously, and the electrical activity of SON neurons and intrauterine pressure were significantly correlated after oxytocin treatment. The phase relationship in these cases between cell activity and uterine activity suggests activation during contraction rather than during relaxation. This together with the inhibitory effect of artificial uterine distension on cell activity suggest that SON neurons are activated as a result of uterine contraction rather than as a result of uterine distension accompanying the movement of fetuses along the uterus. Supporting these findings, the same oxytocin pulse regimen also rapidly induced Fos expression in SON neurons in term pregnant rats. As the SON is within the blood-brain barrier, which is relatively impermeable to oxytocin (27) , the half-life of circulating oxytocin is only 1-2 min, and oxytocin administration does not induce Fos expression in the SON of virgin rats, the injected oxytocin is unlikely to have had a direct effect on SON neurons. Furthermore, it seems that the presence of the oxytocin-receptive uterus is required for SON neuron activation. During parturition there is an increase in the discharge frequency of uterine afferent nerves, including the pelvic nerve (28) , which when lesioned prevents the fetus expulsion reflex and reduces oxytocin secretion (29, 30) . Therefore, our data are consistent with the hypothesis that uterine activity can modulate supraoptic neuronal activity before and during delivery.
Unlike the inhibitory effects of uterine distension described here, vaginal distension increases the SON neuron firing rate ( (31, 32) in pregnant and lactating rats. In addition, cervical stimulation can specifically initiate bursting discharges in term pregnant rats. Thus, we suggest that contractile activity in the uterus preceding the first delivery stimulates further oxytocin release that enhances that delivery, facilitating the movement of fetuses along the birth canal. At the point of delivery, stimulation of the cervix and distension of the vagina initiate a burst discharge of oxytocin, which may either facilitate the expulsive phase of delivery or initiate separation of the placenta from the uterus of the next pup for delivery.
Double immunolabeling and firing rate responses showed that enhanced uterine contraction excited vasopressin neurons of the SON as well as oxytocin neurons. It has previously to the intra-SON infusion and in the NTS (C). Pentobarbitone-anesthetized 22-day pregnant rats were infused in the SON with vehicle (aCSF; n ϭ 5 vehicle pulses, n ϭ 7 oxytocin pulses) or benoxathian (BEN; 1 or 10 g/l at 0.8 l/h, begun 30 min before the onset of iv injections and continued throughout duration of pulse treatment; n ϭ 7 and 5 respectively, all given oxytocin pulses) and given iv oxytocin (OXT; o) or vehicle saline pulses (VEH; Ⅺ) for 90 min. By two-way ANOVA, P Ͻ 0.0001 for all data in A; B, a, **, P Ͻ 0.05, by post-hoc test compared with all other groups for the ipsilateral SON; b, *, P Ͻ 0.05 compared with the groups given vehicle or benoxathian infusion of 10 g/l in the SON. C, By one-way ANOVA, P ϭ 0.0601; *, P Ͻ 0.05, by t test compared with vehicle control; t test for all data from oxytocin pulsetreated rats vs. vehicle-treated rats, P Ͻ 0.05. 2 in the ipsilateral and contralateral SON in virgin female rats receiving an intra-SON infusion of benoxathian (s; 1 g/ml; n ϭ 6) or aCSF (Ⅺ; n ϭ 7) before and for 90 min after receiving an ip injection of hypertonic saline (1.5 M NaCl, 4 ml/kg). By two-way ANOVA, across group, P ϭ 0.95 (not significant); between SON sides, P Ͻ 0.05. been reported that both vasopressin neuron Fos expression and vasopressin secretion increase during parturition (33, 34) . The presence of vasopressin V 1 receptors in the uterus that can mediate contractions (35) (36) (37) suggests that vasopressin could augment oxytocin-induced uterine contractions. However, vasopressin V 1 receptor antagonist administration does not delay birth (38) , and it seems likely that the major role of vasopressin in the uterus during parturition is to promote vasoconstriction, which would reduce the risk of hemorrhage after delivery.
Efferents from the uterus to the SON are relayed via the brainstem; increased uterine contractile activity, when artificially or naturally activated by pulsatile oxytocin infusion (8) or during parturition (9), respectively, induces Fos expression in brainstem neurons, including the NTS and ventrolateral medulla, and in the dorsal vagal complex. There is strong neuroanatomical and pharmacological evidence that the noradrenaline released in the SON is from axon terminals of neurons with cell bodies in these brainstem areas. Catecholaminergic neurons in the A1 and A2 regions project to magnocellular SON and PVN neurons (39 -41) , and electrical stimulation of the NTS activates both oxytocin and vasopressin neurons in the SON (11) . Directly projecting A2 neurons of the NTS have been implicated in the brainstem drive to oxytocin neurons (42) , whereas A1 neurons seem to selectively regulate the vasopressin neurons (40) . We now show that giving oxytocin pulses to term pregnant rats (enhancing uterine contractile activity) induces noradrenaline release in the SON, observed mainly as sudden peaks, and that rats in which parturition is imminent have higher basal extracellular noradrenaline content in the SON, confirming our previous reports of increased noradrenaline content in the SON just before and during spontaneous parturition (16) . Furthermore, we have shown, using retrograde tracing techniques, that NTS neurons projecting to the SON express tyrosine hydroxylase (a rate-limiting enzyme in noradrenaline synthesis) and are activated (express Fos) during parturition (12) .
We show here for the first time that an ␣ 1 -receptor noradrenergic antagonist attenuated Fos expression in the SON induced by driving uterine contractile activity. In conjunction with the data showing that increased uterine contractile activity correlates with increased SON neuron firing rate and Fos expression and the increase in peaks of noradrenaline release in the SON, these data indicate a physiological role for endogenous noradrenaline in the activation of oxytocin neurons at parturition. Noradrenaline acts on both ␣ 1 -and ␣ 2 -adrenoceptors in the SON [respectively, excitatory (43, 44) and presynaptic inhibitory (45, 46) ], and here we used a selective ␣ 1 -adrenoceptor antagonist, benoxathian (47) , previously shown to be effective in inhibiting the oxytocin neuron firing rate (48) . In fact, benoxathian has previously been shown to inhibit the CCK-induced increase in the oxytocin neuron firing rate (48) , and in preliminary experiments we found that it also restrains CCK-induced Fos expression in the SON compared with vehicle (307 Ϯ 149 vs. 805 Ϯ 199 positive neurons/mm 2 , respectively; P Ͻ 0.05). Therefore, the effects on Fos expression that we report here probably reflect prevention of an excitatory action of noradrenaline on oxytocin and vasopressin neurons. Thus, these data support previous reports of intracerebral noradrenaline increasing oxytocin secretion (49) and SON neuron Fos expression (50) , and ␣-adrenergic antagonist administration inhibiting basal and stimulated oxytocin neuron firing rates (48) and delaying the milk ejection reflex (51) .
An ␣ 1 -noradrenergic agonist has previously been shown to modulate the firing pattern in SON neurons in vitro (52) to produce clustered spike discharge, suggesting that it may facilitate the high frequency bursting activity of oxytocin cells observed during parturition and the milk ejection reflex. However, in the experiments reported here, uterine contractions alone did not induce burst-like activation; it is possible that during parturition bursts may be specifically triggered by vagino/cervical activation during passage of the fetus or placenta, as bursts can be evoked in oxytocin cells in late pregnant rats by vaginal probing (53) . Thus, the peaks of noradrenaline release observed in the SON in parturient rats, some of which were in labor and delivered pups, albeit slowly, under anesthesia, may reflect activation not present in the rats anesthetized with urethane for electrophysiological experiments, in which movement of the fetuses was also obstructed by insertion of balloons. However, the background elevation of the noradrenaline concentration in parturient rats, presumably reflecting increased tonic activity of the noradrenergic innervation of the SON during labor, probably contributes to the elevated oxytocin cell activity.
However, a large proportion of the NTS neurons that express Fos in parturition or after oxytocin-induced uterine contractions and that project to the SON do not contain tyrosine hydroxylase (8, 12) , so another neurotransmitter(s)/ factor(s) appears to be additionally required for (or is capable of) induction of oxytocin neuron activity and secretion. Whether noradrenaline causes the enhanced basal Fos expression in the SON on day 22 of pregnancy in control rats cannot easily be shown by seeking changes in Fos expression. In other preliminary experiments, benoxathian infusion into the SON for up to 5 h before and during birth in conscious rats was unable to reduce Fos expression during birth compared with that in vehicle-infused controls. Therefore, the signal(s) that induced basal Fos expression before birth was not predominantly noradrenergic, and/or once the peptide product of the Fos gene was generated, it could not be switched off by simply removing the source of the excitatory signal, and the protein remained in the cell for a time depending upon its stability. Local factors within the SON may also be required to induce neuronal burst firing. Noradrenaline has been implicated in regulating oxytocin release from the dendrites of oxytocin neurons in lactation (54) and inducing changes in morphology of SON neurons (55); both phenomena are exhibited during parturition and contribute to the generation of burst firing (56) . Release of oxytocin from dendrites within the SON increases during parturition and prevention of its actions via the oxytocin receptor (57, 58) with a local infusion of oxytocin antagonist inhibits oxytocin release in the SON and delays pup births (59); while oxytocin infusion into the SON can induce SON neuron Fos expression (preliminary findings). So it is possible that noradrenaline contributes to the enhanced firing rate and Fos expression in SON neurons during parturition by regulating local dendritic oxytocin release. Either the anesthetized rat model used here or uterine contraction alone is insufficient to permit burst firing of SON neurons to occur, although burst firing can be observed under urethane anesthesia during the milk ejection reflex in lactating rats (60) . As local vasopressin release does not increase in the SON during parturition (57) , it is unlikely to contribute to the induction of Fos in our model, even though vasopressin is released within the SON under other physiological circumstances, and vasopressin infusion in the SON induces SON neuron Fos expression (61) .
Although both oxytocin and vasopressin neurons can be activated by cardiovascular, osmotic, and other abdominal stimuli as well as by parturition and suckling, it is unlikely that changes in blood pressure or volume could have accounted for their activation. Blood pressure was not measured in these experiments, but previous measurements of blood pressure did not show any difference between oxytocin-and saline-treated pregnant female rats (8) . We have also reported that the same oxytocin pulse treatment does not activate neurons in the subfornical organ or area postrema (8) , areas that express Fos after osmotic stimulation (62) or after changes in blood pressure (63, 64) and that project to the SON. However decreased, and not increased, blood volume increases Fos expression in SON neurons (63) , and oxytocin has variously been reported to have no effect (65) , to decrease (66), or to increase (67) arterial blood pressure. Certainly, the changes in blood volume imposed in our experiments amount to less than 5% of the blood volume of a pregnant rat, and saline injections do not in themselves increase neuron activation. In any case, the induced changes in plasma oxytocin in our experiments mimic normal changes during parturition, and presumably any uterine contraction-mediated blood pressure changes associated with that.
In our experiments, benoxathian attenuated Fos expression in the SON, both ipsi-and contralateral to the infusion site. This may reflect diffusion of benoxathian across the hypothalamus to the contralateral side, cross-talk between the two SON (68, 69) , or actions in regions of the hypothalamus, for example the anterior periventricular structures (70) , that have bilateral projections to the SON. The extent of diffusion of the antagonist is unknown for this experiment, but lesion of the anterior periventricular region does not disrupt the parturition process (71) . An alternative explanation, however, is that action in even one SON reduces oxytocin release and so reduces uterine contractile activity, resulting in reduced feedback drive to both nuclei. Benoxathian did not produce a general reduction in SON neuron responsiveness, as it did not prevent SON neuron Fos expression in response to a hyperosmotic stimulus, which involves both a direct increase in activation by the osmoresponsive SON neurons and trans-synaptic activation through osmoresponsive neurons in the lamina terminalis. Although the lack of effect against a hyperosmotic stimulus could be because it induced a large activation of the neurons, benoxathian has previously been reported to inhibit hyperexcited SON neurons under other circumstances (48) . Therefore, overall, our data indicate that increasing uterine contractile activity at term activates oxytocin and vasopressin neurons in the SON at least in part via noradrenergic action in the SON.
